INS and Hyperglycemia: These results lend further support to the beneficial role of MP in the context of induction immunosuppressive therapy in pancreas and islet transplantation and should spur further investigations into the rescue of beta-cell function during pancreas or islet rejection, even when hyperglycemia and the need for insulin is present.